IONIS PHARMACEUTICALS, INC DEF 14A 5-24-2017

Company

IONIS PHARMACEUTICALS INC

Filed

April 10, 2017

Period of Report

May 24, 2017

Accession Number

0001140361-17-015262

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →